Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (21132)	5/19/1998 3:46:00 PM
From: Jack Be Quick	Respond to of 32384

Henry, re:<< Where did you see a rec by them? >> Umm...on Zanks, maybe?!

To: Henry Niman who wrote (21132)	5/19/1998 4:28:00 PM
From: Jack Be Quick	Read Replies (2) \| Respond to of 32384

Henry, I remember more now. The VICL rec. was issued by Manson's senior biotech analyst, Hank Hill. As I recall, Mr. Hill stated "this stock is such an easy double, I rate it #1, and I am willing to stake my cartoon reputation on that!". Speaking of which, I am still trying to track down info. on Vical's price action over the last couple of years. It appears to me that the stock is trading $3 to $4 dollars lower than it was 2 years ago. I don't think this can be right. I've asked TonyT but he hasn't gotten back to me yet. Can anyone else help me out with this? Tia, John